BR112023021825A2 - Método para tratar síndrome da angústia respiratória aguda (sara) em pacientes específicos utilizando precursores de linhagem mesenquimal ou células tronco - Google Patents
Método para tratar síndrome da angústia respiratória aguda (sara) em pacientes específicos utilizando precursores de linhagem mesenquimal ou células troncoInfo
- Publication number
- BR112023021825A2 BR112023021825A2 BR112023021825A BR112023021825A BR112023021825A2 BR 112023021825 A2 BR112023021825 A2 BR 112023021825A2 BR 112023021825 A BR112023021825 A BR 112023021825A BR 112023021825 A BR112023021825 A BR 112023021825A BR 112023021825 A2 BR112023021825 A2 BR 112023021825A2
- Authority
- BR
- Brazil
- Prior art keywords
- stem cells
- respiratory distress
- distress syndrome
- acute respiratory
- ards
- Prior art date
Links
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 title abstract 4
- 239000002243 precursor Substances 0.000 title abstract 3
- 210000000130 stem cell Anatomy 0.000 title abstract 3
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 abstract 2
- 201000000028 adult respiratory distress syndrome Diseases 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
método para tratar síndrome da angústia respiratória aguda (sara) em pacientes específicos utilizando precursores de linhagem mesenquimal ou células tronco. a presente divulgação se refere a métodos para tratar ou prevenir síndrome da angústia respiratória aguda (sara) em um sujeito que necessita do mesmo, em que o método compreende administrar ao sujeito uma composição que compreende um precursor de linhagem mesenquimal ou células tronco (mlpscs).
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021901214A AU2021901214A0 (en) | 2021-04-23 | Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells | |
AU2021902180A AU2021902180A0 (en) | 2021-07-15 | Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells | |
AU2022900260A AU2022900260A0 (en) | 2022-02-09 | Method for treating acute respiratory distress syndrome (ARDS) in specific patients using mesenchymal lineage precursor or stem cells | |
AU2022900372A AU2022900372A0 (en) | 2022-02-18 | Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells | |
PCT/IB2022/053762 WO2022224206A1 (en) | 2021-04-23 | 2022-04-22 | Method for treating acute respiratory distress syndrome (ards) in specific patients using mesenchymal lineage precursor or stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112023021825A2 true BR112023021825A2 (pt) | 2024-02-06 |
Family
ID=81585202
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023021840A BR112023021840A2 (pt) | 2021-04-23 | 2022-04-22 | Método para tratar síndrome da dificuldade respiratória aguda (ards) com o uso de percursor de linhagem mesenquimal ou células-tronco |
BR112023021825A BR112023021825A2 (pt) | 2021-04-23 | 2022-04-22 | Método para tratar síndrome da angústia respiratória aguda (sara) em pacientes específicos utilizando precursores de linhagem mesenquimal ou células tronco |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023021840A BR112023021840A2 (pt) | 2021-04-23 | 2022-04-22 | Método para tratar síndrome da dificuldade respiratória aguda (ards) com o uso de percursor de linhagem mesenquimal ou células-tronco |
Country Status (8)
Country | Link |
---|---|
US (2) | US20240207323A1 (pt) |
EP (2) | EP4326295A1 (pt) |
JP (2) | JP2024516173A (pt) |
KR (2) | KR20240001173A (pt) |
AU (2) | AU2022261504A1 (pt) |
BR (2) | BR112023021840A2 (pt) |
CA (2) | CA3216129A1 (pt) |
WO (2) | WO2022224207A1 (pt) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US6251295B1 (en) | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
-
2022
- 2022-04-22 EP EP22724876.2A patent/EP4326295A1/en active Pending
- 2022-04-22 WO PCT/IB2022/053763 patent/WO2022224207A1/en active Application Filing
- 2022-04-22 US US18/556,845 patent/US20240207323A1/en active Pending
- 2022-04-22 AU AU2022261504A patent/AU2022261504A1/en active Pending
- 2022-04-22 JP JP2023564584A patent/JP2024516173A/ja active Pending
- 2022-04-22 KR KR1020237039593A patent/KR20240001173A/ko unknown
- 2022-04-22 BR BR112023021840A patent/BR112023021840A2/pt unknown
- 2022-04-22 CA CA3216129A patent/CA3216129A1/en active Pending
- 2022-04-22 EP EP22721854.2A patent/EP4326294A1/en active Pending
- 2022-04-22 BR BR112023021825A patent/BR112023021825A2/pt unknown
- 2022-04-22 US US18/556,827 patent/US20240197787A1/en active Pending
- 2022-04-22 CA CA3216121A patent/CA3216121A1/en active Pending
- 2022-04-22 WO PCT/IB2022/053762 patent/WO2022224206A1/en active Application Filing
- 2022-04-22 KR KR1020237039592A patent/KR20240001172A/ko unknown
- 2022-04-22 JP JP2023564582A patent/JP2024516172A/ja active Pending
- 2022-04-22 AU AU2022260822A patent/AU2022260822A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4326294A1 (en) | 2024-02-28 |
CA3216121A1 (en) | 2022-10-27 |
WO2022224206A1 (en) | 2022-10-27 |
JP2024516172A (ja) | 2024-04-12 |
BR112023021840A2 (pt) | 2024-02-06 |
US20240207323A1 (en) | 2024-06-27 |
CA3216129A1 (en) | 2022-10-27 |
EP4326295A1 (en) | 2024-02-28 |
AU2022260822A1 (en) | 2023-11-30 |
WO2022224207A1 (en) | 2022-10-27 |
US20240197787A1 (en) | 2024-06-20 |
JP2024516173A (ja) | 2024-04-12 |
KR20240001173A (ko) | 2024-01-03 |
KR20240001172A (ko) | 2024-01-03 |
AU2022261504A1 (en) | 2023-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018075734A2 (pt) | composto, composição farmacêutica, método para tratar um paciente com uma doença ou condição mediada pelo menos em parte por fxr, e, uso de um composto. | |
MX339658B (es) | Combinaciones y metodos para administracion subcutanea de inmunoglobulina y hialuronidasa. | |
AR093386A1 (es) | Composicion para tratar la diabetes o la diabesidad que comprende un analogo de oxintomodulina y metodo de tratamiento | |
BR112022020042A2 (pt) | Método para tratar hiperinflamação com o uso de células-tronco ou precursoras de linhagem mesenquimal | |
BR112019007815A2 (pt) | composição de curativo tópico e método de preparação do mesmo para o tratamento de tecido de pele danificado | |
MX2022012424A (es) | Tratamiento del sindrome del cromosoma x fragil con canabidiol. | |
MX2009004776A (es) | Celulas madre mesenquimaticas derivadas de medula osea como una fuente de progenitores neurales. | |
BR112014009365A2 (pt) | método para inibição da atividade de deubiquitinação | |
BR112022010633A2 (pt) | Composto de fórmula, composição farmacêutica, uso de um composto, método para o tratamento ou profilaxia de câncer de tireoide e invenção | |
BR112023021825A2 (pt) | Método para tratar síndrome da angústia respiratória aguda (sara) em pacientes específicos utilizando precursores de linhagem mesenquimal ou células tronco | |
MX2014008521A (es) | Combinacion de beta-hidroxi-beta-metil-butirato, arginina y glutamina, para usarse en el tratamiento de ulceras diabeticas. | |
MX2021007076A (es) | Tratamiento para el sindrome de supresion del 22q11.2 con cannabidiol. | |
BR112023018654A2 (pt) | Compostos antibacterianos | |
BR112017006160A2 (pt) | matriz para restaurar o tecido mole e seu método de produção | |
MX2023010948A (es) | Compuestos antibacterianos. | |
BR112022017557A2 (pt) | Método para tratar doenças pulmonares inflamatórias com o uso de células-tronco ou precursoras de linhagem mesenquimal | |
BR112018014723A2 (pt) | fantasmas bacterianos para o tratamento de câncer | |
BR112022018022A2 (pt) | Método para tratar doença inflamatória intestinal ii | |
CO2019008575A2 (es) | Métodos para tratar infecciones bacterianas | |
BR112022017560A2 (pt) | Método para tratar doença inflamatória intestinal i | |
WO2014144731A3 (en) | Compositions comprising hypoxia inducible factor-1 alpha and methods of using the same | |
BR112014027646A2 (pt) | método para tratar um indivíduo quanto a um distúrbio proliferativo celular, e método para prevenir ou inibir a perda induzida por uv da atividade de udp-glucuronosiltransferase (ugt) em um indivíduo | |
AU2022900260A0 (en) | Method for treating acute respiratory distress syndrome (ARDS) in specific patients using mesenchymal lineage precursor or stem cells | |
BR112022022515A2 (pt) | Compostos de metiltionínio para uso no tratamento de covid-19 | |
BR112022020392A2 (pt) | Método para tratar um indivíduo que tem doença de huntington, inibidor do bromodomínio 9, e, uso de um inibidor do bromodomínio 9 |